Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats.
- 1 March 2002
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 33 (3), 775-781
- https://doi.org/10.1161/hs0302.103734
Abstract
Background and Purpose — Mitogen-activated protein kinase (MAPK) may be associated with the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage (SAH). This study aimed to clarify the role of MAPK expression and activation during cerebral vasospasm and to evaluate the therapeutic effect on cerebral vasospasm using an antisense MAPK oligodeoxynucleotide (ODN). Methods — Antisense MAPK, sense MAPK, or scrambled ODN was injected into the rats intracisternally. We used a single-hemorrhage experimental SAH model to assess vasospasm in the basilar arteries at 30 minutes, 1 day, and 2 days after SAH by cross-sectional area measurement and other histological parameters. Immunohistochemistry and Western blot analysis were used to quantify MAPK expression and activation. In addition, a double-hemorrhage rat SAH model was used to test the effect of post-SAH treatment with antisense MAPK ODN. Results — Antisense MAPK therapy significantly inhibited cerebral vasospasm when compared with sense MAPK or scrambled ODN treatment on day 2. The immunohistochemistry and Western blotting performed in the basilar artery of rats that received antisense MAPK ODN demonstrated inhibition of MAPK and phosphorylated MAPK on day 2. In post-SAH treatment study, antisense ODN reduced MAPK and phosphorylated MAPK in the basilar artery and attenuated cerebral vasospasm. Conclusions — MAPK activation, but not expression, might be implicated with sustained smooth muscle contraction during cerebral vasospasm after SAH. This study suggests that antisense MAPK ODN strategy is an effective treatment against cerebral vasospasm.Keywords
This publication has 27 references indexed in Scilit:
- Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cellsJournal of Neurosurgery, 2001
- Effects of MAPK inhibitors on cerebral vasospasm in a dog double hemorrhage modelJournal of Neurosurgery, 2000
- Tumour necrosis factor‐α‐ and interleukin‐1β‐stimulated cell proliferation through activation of mitogen‐activated protein kinase in canine tracheal smooth muscle cellsBritish Journal of Pharmacology, 2000
- Involvement of mitogen-activated protein kinase in hippocampal long-term potentiationJournal of Biomedical Science, 1999
- Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in ratsJCI Insight, 1999
- Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhageJournal of Neurosurgery, 1999
- Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar arteryJournal of Neurosurgery, 1999
- Activation of Protein Kinases in Canine Basilar Artery in VasospasmJournal of Cerebral Blood Flow & Metabolism, 1999
- BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injectionLife Sciences, 1993
- Significance of vasospasm in the treatment of ruptured intracranial aneurysmsJournal of Neurosurgery, 1977